drugset / Trial / NCT02033629

Low Remifentanil Target Controlled Infusions for Cardiac Surgery

NCT02033629

Phase 3 Completed 75 enrolled Imam Abdulrahman Bin Faisal University
RandomizedParallel-groupTriple-blindTreatment

Summary

The development of target effect-site controlled concentrations (TCI) of remifentanil have gained increasing acceptance during cardiac surgery as regarding the resulting of hemodynamic stability and early extubation. The use of low-dose opioid technique has been progressively used nowadays because of its ceiling effect to attenuate cardiovascular responses to noxious stimuli. We hypothesize that the use of low target remifentanil effect site concentrations may provide comparable shorter times to tracheal extubation and hemodynamic stability to the use of high remifentanil Ce during target-controlled propofol anesthesia for cardiac surgery.

Timeline

Start
2014-05
Primary completion
2019-05-01
Completion
2019-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 1 ng/ml Intravenous
Subject Remifentanil Small molecule 2 ng/ml Intravenous
Subject Remifentanil Small molecule 3 ng/ml Intravenous